Leaflet WELLBUTRIN SR 150mg prolonged-release film-coated tablets


Indicated for: depression; smoking cessation

Substance: bupropion (antidepressant)

ATC: N06AX12 (Nervous system | Antidepressants | Other antidepressants)

Bupropionum is a medication used for the treatment of major depression and as an aid in smoking cessation. It is a dopamine and norepinephrine reuptake inhibitor that helps improve mood and reduce nicotine withdrawal symptoms.

The medication is taken orally, usually once or twice daily, as directed by a doctor. The dosage is adjusted based on the patient's response and the purpose of treatment.

Common side effects include insomnia, dry mouth, nausea, dizziness, and anxiety. In rare cases, more severe adverse effects such as seizures or severe allergic reactions may occur.

Bupropionum is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, it is important for patients to strictly adhere to the prescribed dosage to minimize the risk of serious adverse effects.

General data about WELLBUTRIN SR 150mg

  • Substance: bupropion
  • Date of last drug list: 01-07-2013
  • Commercial code: W08424001
  • Concentration: 150mg
  • Pharmaceutical form: prolonged-release film-coated tablets
  • Quantity: 60
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for bupropion

  • 150mg
  • 300mg

Combinations with other substances